Results 201 to 210 of about 3,304,556 (301)

Dementia with Lewy bodies and amyloid pathology: Eligible for anti‐amyloid treatment or not?

Alzheimer's &Dementia, Volume 22, Issue 10, October 2026.
Abstract In the future, treatment of dementia will be personalized, targeted to contributing pathologies, rather than the clinical syndrome. Anti‐amyloid drugs for Alzheimer's disease are the first approved drugs; however, the impact of co‑pathology on the treatment effects remains incomplete.
Lieza G Exalto, Juliette L van Alphen, Frederik Barkhof, Charlotte Teunissen, Everard G. B Vijverberg, Dag Aarsland, Afina W Lemstra   +6 more
wiley   +1 more source

Access and Reimbursement for Artificial Intelligence in Radiology: A Central Asian Perspective. [PDF]

Korean J Radiol
Dautov T, Darbaeva A, Aimagambetova Z, Polushkin V.   +3 more
europepmc   +1 more source

CO‐Rebreathing in Essential Thrombocythemia and Polycythemia Vera. A Revival of an Old Methodology to Improve Diagnosis and Phlebotomy Decisions

Cancer Medicine, Volume 15, Issue 10, October 2026.
ABSTRACT The diagnostic landscape for the Philadelphia‐negative myeloproliferative neoplasms (MPNs), particularly in distinguishing Essential Thrombocythemia (ET) from Polycythemia Vera (PV), is compromised. The gold standard for diagnosing PV—measurement of red cell mass (RCM) by radioisotope dilution—has been largely abandoned, leading to widespread ...
Hans C. Hasselbalch, Morten Kranker Larsen, Lea Løffler, Camilla Andersen, Isabella Davidsen, Mette Grymer Jensen, Jonas Bechlund, Lasse Kjær, Vibe Skov, Henning Bay Nielsen, Carsten Lundby   +10 more
wiley   +1 more source

Next‐Generation Sequencing‐Based Molecular Profiling and Management of Advanced Solid Tumors: A Real‐World Experience in a Community‐Based Academic Cancer Center

Cancer Medicine, Volume 15, Issue 10, October 2026.
ABSTRACT Background Advances in molecular and cell biology have led to a paradigm shift in cancer management. We implemented next‐generation sequencing (NGS) at our community‐based academic cancer center over a decade ago. We sought to optimize the use of genomics and understand its impact in identifying actionable genomic alterations to determine ...
Gayathri Moorthy, Annette Sereika, Karen Kaul, Megan Parilla, Mir B. Alikhan, Michael Bouma, Dyson Wake, Peter J. Hulick, Henry M. Dunnenberger, Linda M. Sabatini, Mathew Yang, Kathy A. Mangold, Erin Proctor, Nicholas Evans, Nicholas Miller, Donald L. Helseth Jr, Darryck Maurer, Justin Brueck, Janardan Khandekar, Bruce Brockstein   +19 more
wiley   +1 more source

AI-RADS: a reporting-layer framework for interpretable, action-oriented radiology AI output to support post-market surveillance

The Royal College of Radiologists Open
Maximilian Russe, Anna Fink, Carl Simon, Kai Kästingschäfer, Fabian Bamberg, Alexander Rau   +5 more
doaj   +1 more source

Primary mediastinal ectopic thyroid in a 43-year-old woman: A diagnostic and surgical challenge - a case report and literature review. [PDF]

Medicine (Baltimore)
Wang Z, Liang S, Li K, Lu X, Li X, Sun D.   +5 more
europepmc   +1 more source

New Primary and Secondary Prevention Measures for Cutaneous Melanoma: A Systematic Review

Cancer Reports, Volume 9, Issue 10, October 2026.
ABSTRACT Background Cutaneous melanoma is the deadliest type of skin cancer, with increasing incidence and mortality rates. Therefore, primary and secondary prevention are of utmost importance. Claims The objective is to evaluate new recent evidence on primary and secondary prevention strategies for cutaneous melanoma.
Maria Palau–del–Valle, Elena Bendala–Tufanisco, María Amparo López–Ruiz   +2 more
wiley   +1 more source

Clinical AI Beyond Development: A Scoping Review of Deployment-Related Robustness, Algorithmovigilance, and Lifecycle Oversight. [PDF]

Healthcare (Basel)
El Arab RA, Hussein Mustafa M, Almagharbeh WT, Ayoub MY, Alsanawi F, Almathen F, Almosabeh R, Al Talaq M.   +7 more
europepmc   +1 more source

Operationalizing Precision Medicine in Drug Development: Predictive Biomarkers, Companion Diagnostics, and Regulatory Pathways

Clinical Pharmacology &Therapeutics, Volume 120, Issue 4, Page 914-929, October 2026.
Precision medicine offers the opportunity to improve the benefit–risk profile of new therapies by prospectively identifying patients most likely to respond or least likely to experience harm; however, its systematic integration into drug development remains inconsistent outside oncology.
Ingrid Holst‐Laubjerg, José M.A. Moreira   +1 more
wiley   +1 more source